Explorer les evidences

5,35 %The overall prevalence of HIV infection in this study was 5.35%.

NigeriaVIH/sidapublié 2021Journal of medical virologyPubMeddocument de 11 observations

Nigeria has the fourth largest burden of HIV globally.

NigeriaVIH/sidapublié 2022JMIR public health and surveillancePubMeddocument de 5 observations

7,5 %The North-Central zone of Nigeria has an HIV prevalence rate of 7.5%.

NigeriaVIH/sidapublié 2021Nigerian journal of clinical practicePubMeddocument de 7 observations

28,2 %Among 168 people living with HIV (PLHIV) studied, 28.2% had good knowledge of mother-to-child transmission (MTCT) of HIV.

NigeriaVIH/sidapublié 2021The Pan African medical journalPubMeddocument de 5 observations

2,17 AORRespondents living with HIV had higher odds for sexual violence (AOR: 2.17; 95% CI: 1.55–3.05; p < 0.001).

NigeriaVIH/sidaobservé 2021publié 2022BMC public healthPubMeddocument de 12 observations

Women with primary Toxoplasma gondii and HIV coinfection had lower CD4+ T-cell count than those with toxoplasmosis monoinfection.

NigeriaToxoplasma gondii infection · VIH/sidapublié 2020Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument de 8 observations

100 %Minor PI resistance-associated mutation K20I was identified in 100% of subtype G/UG HIV-1 isolates.

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 11 observations

98 %246 (98.0%) of the participants were retained in care.

NigeriaVIH/sidapublié 2021PloS onePubMeddocument de 10 observations

9,9 adjusted_odds_ratioChildren living with HIV were 10 times more likely to have been told their status if their caregivers believed that disclosure had benefits, with an adjusted odds ratio of 9.9 (95% CI = 3.2–15.1).

NigeriaVIH/sidapublié 2020BMC public healthPubMeddocument de 5 observations

23,7 %Less than a quarter of adolescents and young adults (AYA) in Nigeria had ever tested for HIV, specifically 23.7%.

NigeriaVIH/sidaobservé 2017publié 2020PloS onePubMeddocument de 4 observations

10 clientsBetween January 2023 to December 2023, 10 clients on antiretroviral drugs in rural areas in Delta, Ekiti and Osun states accessed Drug Information Services.

NigeriaVIH/sidaobservé January 2023 to December 2023publié 2025Currents in pharmacy teaching & learningPubMeddocument de 9 observations

66,5 %The total attitude score towards HIV PEP among doctors was 66.5% with a standard deviation of 12.2%.

NigeriaVIH/sidapublié 2020West African journal of medicinePubMeddocument de 6 observations

5,1 %C. krusei was isolated in 5.1% of the patients.

NigeriaC. krusei · oral candidiasis · VIH/sidapublié 2026BMC infectious diseasesPubMeddocument de 11 observations

100 %In the ART Surge, treatment initiation rate was 100%.

NigeriaVIH/sidapublié 2021PloS onePubMeddocument de 13 observations

0 %Using malaria microscopy, the prevalence of malaria parasitaemia was 0% in HIV-negative persons.

Nigeriapaludisme · VIH/sidaobservé 2018–2019publié 2024BMC infectious diseasesPubMeddocument de 15 observations

-6,3 per_weekIn a clinic in Nigeria, antiretroviral therapy initiations per week decreased by 6.3 points after the beginning of the pandemic.

NigeriaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 4 observations

Maternal HIV infection is associated with small for gestational age.

NigeriaVIH/sidapublié 2019West African journal of medicinePubMeddocument de 4 observations

98,6 %Among HIV-positive pregnant women in Kaduna State, 98.6% had a positive attitude towards antiretroviral therapy.

NigeriaVIH/sidapublié 2025Scientific reportsPubMeddocument de 4 observations

66,7 %Among patients with ≥2 viral load measurements on tenofovir, lamivudine, and dolutegravir (TLD), viral resuppression to ≤50 copies/ml at follow-up occurred in 66.7% of those with initial low-level viremia (51–199 copies/ml).

NigeriaVIH/sidapublié 2024AIDS (London, England)PubMeddocument de 8 observations

1,44 %HIV prevalence among participants aged ≥18 months in the Nigeria AIDS Indicator and Impact Survey (NAIIS) 2018 was 1.44%.

NigeriaVIH/sidaobservé 2018publié 2022PLOS global public healtheurope_pmcdocument de 10 observations

38 %38% of the ART clients investigated were last receiving three- to five-month multi-month dispensing, and 10% of those on three- to five-month multi-month dispensing had interrupted treatment.

NigeriaVIH/sidaobservé 2000-2020publié 2021BMC public healthPubMeddocument de 12 observations

7,7 %The rate of TB and HIV coinfection was 7.7%.

Nigeriatuberculose · VIH/sidapublié 2020Nigerian journal of clinical practicePubMeddocument de 4 observations

16,1 %HBsAg prevalence among 310 HIV-positive individuals in Southwestern Nigeria was 16.1% (50/310).

Nigeriahépatite B · VIH/sidaobservé June 2017 to August 2017publié 2021Virology journalPubMeddocument de 6 observations

99 %Among participants with viral load results (n = 199), 99% were virally suppressed (<1000 copies/ml) at 12 months.

NigeriaVIH/sidaobservé 12 monthspublié 2023PloS onePubMeddocument de 12 observations

64,3 μg/LHIV-positive pregnant women had significantly lower mean serum selenium concentration compared with HIV-negative pregnant women (64.3 ± 19.6 μg/L vs. 100.1 ± 30.9 μg/L).

NigeriaVIH/sidapublié 2023Annals of African medicinePubMeddocument de 5 observations